2019
DOI: 10.1016/j.jddst.2019.101253
|View full text |Cite
|
Sign up to set email alerts
|

Harnessing nanotechnology for enhanced topical delivery of clindamycin phosphate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 20 publications
(11 citation statements)
references
References 47 publications
0
10
0
1
Order By: Relevance
“…Here, the subcutaneous layer acts as a reservoir to deliver drug progressively to the viable dermis layer. The slower penetration of the developed formulation will also lead to reduced systemic toxicity [33,35]. The study finding that the drug resides on the top of the dermal layer confirmed an enhanced therapeutic drug profile to treat fungal infection [39,40].…”
Section: Tape Stripping Studymentioning
confidence: 76%
See 1 more Smart Citation
“…Here, the subcutaneous layer acts as a reservoir to deliver drug progressively to the viable dermis layer. The slower penetration of the developed formulation will also lead to reduced systemic toxicity [33,35]. The study finding that the drug resides on the top of the dermal layer confirmed an enhanced therapeutic drug profile to treat fungal infection [39,40].…”
Section: Tape Stripping Studymentioning
confidence: 76%
“…The process seems to be following the Gibbs-Thompson equation [32]. The amorphous structure of the TH-NS established by the result obtained is desirable for enhanced drug entrapment within the NS structure [33].…”
Section: Thermoanalytical Technique (Dsc)mentioning
confidence: 93%
“…The PDI signifies the distribution of the size of the nanocarriers in the formulation. PDI values less than 0.5 signify that the formulation is monodispersed (homogeneity), whereas a PDI value more than 0.5 signifies the polydispersity of the formulation [ 60 ].…”
Section: Resultsmentioning
confidence: 99%
“…Clindamycin has been shown to be effective, safe, and well-tolerated after topical application, and it is currently available in a variety of different vehicles differing in the amount of water, alcohol and oil, including lotions, solutions, gels, and foams [ 8 ]. Although widely used in dermatology, the major issue of conventional clindamycin topical formulations for effective treatment is the hydrophilic nature of clindamycin (log P = 0.5), not suitable for skin penetration and accumulation in the pilosebaceous structures as lipophilic environment [ 9 , 10 ]. Clindamycin is a water-soluble weak base (pKa 7.72), which is mostly in ionized form at physiological pH [ 11 ], and it is usually classified in class III of the Biopharmaceutics Classification System (BCS), with good aqueous solubility and poor membrane permeability.…”
Section: Introductionmentioning
confidence: 99%
“…Clindamycin is a water-soluble weak base (pKa 7.72), which is mostly in ionized form at physiological pH [ 11 ], and it is usually classified in class III of the Biopharmaceutics Classification System (BCS), with good aqueous solubility and poor membrane permeability. Based on the drawbacks of clindamycin itself and its conventional formulations, several vesicular and particulate nanodelivery systems of clindamycin have been developed in order to enhance the delivery of clindamycin to the intended site of action after topical application [ 9 , 12 , 13 , 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%